rhIL-11

DRUG5 trials

Conditions

Chemotherapy-induced ThrombocytopeniaInflammatory Bowel DiseasePancytopenia Due to ChemotherapyPurpura, Thrombocytopenic, IdiopathicRecurrent Colorectal CarcinomaThrombopeniaUlcerative Colitis

Phase 1

Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis

TerminatedNCT00038922

Wyeth is now a wholly owned subsidiary of PfizerInflammatory Bowel Disease, Ulcerative Colitis

Updated: 2006-05-18

Phase 2

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

NCT03823079

Fudan UniversityRecurrent Colorectal Carcinoma, Thrombopenia

Start: 2019-02-01End: 2020-02-01Target: 50Updated: 2019-01-30

Phase 3

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

CompletedNCT01663441

Beijing Northland Biotech. Co., Ltd.Chemotherapy-induced Thrombocytopenia

Start: 2015-03-31End: 2017-08-31Updated: 2020-09-16

Phase 4

Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL

CompletedNCT02314273

Shanghai Children's Medical CenterPancytopenia Due to Chemotherapy

Start: 2011-09-30End: 2014-04-30Updated: 2014-12-11

Unknown Phase

Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia

WithdrawnNCT01317966

Ming HouPurpura, Thrombocytopenic, Idiopathic

Start: 2011-03-31End: 2012-03-31Updated: 2016-04-20